Literature DB >> 11830513

High mobility group protein I(Y): a candidate architectural protein for chromosomal rearrangements in prostate cancer cells.

Natsuki Takaha1, Anita L Hawkins, Constance A Griffin, William B Isaacs, Donald S Coffey.   

Abstract

The extent of chromosomal rearrangements correlates positively with the level of expression of the nuclear matrix high mobility group (HMG) proteins HMGI(Y) when tested in three human prostate cancer cell lines (PC-3 > DU-145 > LNCaP). HMGI(Y), topoisomerase II, and A-T-rich sequences have been reported to be located at the base of the DNA loop domains in both the nucleus and chromosome and are juxtapositioned for chromosomal rearrangement. Transfecting and expressing full-length HMG-I into the LNCaP cell markedly enhanced the presence and heterogeneity of unbalanced (nonreciprocal) chromosomal rearrangements but not of balanced rearrangements. Unbalanced chromosomal rearrangements are common in solid human tumors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11830513

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Comparison of nuclear matrix proteins between gastric cancer and normal gastric tissue.

Authors:  Qin-Xian Zhang; Yi Ding; Zhuo Li; Xiao-Ping Le; Wei Zhang; Ling Sun; Hui-Rong Shi
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

Review 2.  The high mobility group A1 molecular switch: turning on cancer - can we turn it off?

Authors:  Tait H Huso; Linda M S Resar
Journal:  Expert Opin Ther Targets       Date:  2014-03-31       Impact factor: 6.902

3.  c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus.

Authors:  Sherif F Louis; Bart J Vermolen; Yuval Garini; Ian T Young; Amanda Guffei; Zelda Lichtensztejn; Fabien Kuttler; Tony C Y Chuang; Sharareh Moshir; Virginie Mougey; Alice Y C Chuang; Paul Donald Kerr; Thierry Fest; Petra Boukamp; Sabine Mai
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-27       Impact factor: 11.205

4.  Gene-specific nucleotide excision repair is impaired in human cells expressing elevated levels of high mobility group A1 nonhistone proteins.

Authors:  Scott C Maloney; Jennifer E Adair; Michael J Smerdon; Raymond Reeves
Journal:  DNA Repair (Amst)       Date:  2007-05-30

Review 5.  High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.

Authors:  S S Liau; E Whang
Journal:  Surgeon       Date:  2009-10       Impact factor: 2.392

6.  Determination of high mobility group A1 (HMGA1) expression in hepatocellular carcinoma: a potential prognostic marker.

Authors:  Zhi-Gang Chang; Lian-Yue Yang; Wei Wang; Ji-Xiang Peng; Gen-Wen Huang; Yi-Ming Tao; Xiang Ding
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

Review 7.  The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

Authors:  T F Sumter; L Xian; T Huso; M Koo; Y-T Chang; T N Almasri; L Chia; C Inglis; D Reid; L M S Resar
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

8.  Role of nuclear architecture in epigenetic alterations in cancer.

Authors:  H P Easwaran; S B Baylin
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-03-29

9.  Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression.

Authors:  Jakob Albrethsen; Jaco C Knol; Sander R Piersma; Thang V Pham; Meike de Wit; Sandra Mongera; Beatriz Carvalho; Henk M W Verheul; Remond J A Fijneman; Gerrit A Meijer; Connie R Jimenez
Journal:  Mol Cell Proteomics       Date:  2010-01-20       Impact factor: 5.911

10.  Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells.

Authors:  X-B Shi; L Xue; A-H Ma; C G Tepper; R Gandour-Edwards; H-J Kung; R W deVere White
Journal:  Oncogene       Date:  2012-10-15       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.